Dose-expansion study of OBI-999, a Globo H-targeting antibody-drug conjugate, in patients with advanced solid tumors.
- DOI
- 10.1093/oncolo/oyag249
- Published
- 2026 Aug 6
- Container
- The oncologist
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/oncolo/oyag249,
title = {Dose-expansion study of OBI-999, a Globo H-targeting antibody-drug conjugate, in patients with advanced solid tumors.},
author = {Tsimberidou AM and Sigal D and Varghese A and Vaena D and Bai LY and Chen MH and Yeh CN and Yen CJ and Baysal MA and Chakraborty A and Lee I and Shia CS and Ristoski K and Xu D},
year = {2026},
journal = {The oncologist},
doi = {10.1093/oncolo/oyag249},
url = {https://doi.org/10.1093/oncolo/oyag249}
}RIS
TY - JOUR TI - Dose-expansion study of OBI-999, a Globo H-targeting antibody-drug conjugate, in patients with advanced solid tumors. AU - Tsimberidou AM AU - Sigal D AU - Varghese A AU - Vaena D AU - Bai LY AU - Chen MH AU - Yeh CN AU - Yen CJ AU - Baysal MA AU - Chakraborty A AU - Lee I AU - Shia CS AU - Ristoski K AU - Xu D PY - 2026 JO - The oncologist DO - 10.1093/oncolo/oyag249 UR - https://doi.org/10.1093/oncolo/oyag249 ER -
APA
AM, T., D, S., A, V., D, V., LY, B., MH, C., CN, Y., CJ, Y., MA, B., A, C., I, L., CS, S., K, R., & D, X. (2026). Dose-expansion study of OBI-999, a Globo H-targeting antibody-drug conjugate, in patients with advanced solid tumors.. The oncologist. https://doi.org/10.1093/oncolo/oyag249
Source records
- pubmed · retrieved 2026-09-26T16:10:55.525Z
- europe-pmc · retrieved 2026-09-26T16:10:55.540Z